Latest by Sony Salzman
Melanie Thompson, M.D., provided a round up of this year's successes failures in HIV clinical research at IDWeek 2018 in San Francisco.
With Only 15% of Diagnosed HCV Patients Receiving Treatment, the Non-Profit I-MAK Hopes to Shift the National Conversation on Drug Pricing
The Initiative for Medicines, Access and Knowledge, Inc. (I-MAK) argues that the high price of hepatitis C cure medicines places them out of reach for most people.
Research Is Still Exploring Best Treatment Strategies for Pregnant and Breastfeeding Women, Interactions With Contraceptives
Several new studies presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI) underscore the complex ways that HIV risk and treatment adherence manifest among women of childbearing age.
Researchers at this year's Conference on Retroviruses and Opportunistic Infections (CROI) presented their findings on the ongoing challenges of treating hepatitis C infection among people with HIV.
Panelists at CROI 2018 painted a bleak picture of the scale of the country's addiction crisis, noting that the never-before-seen dynamics of the current drug epidemic require creative approaches to HIV treatment and prevention among people who inject...
Study highlights the need for PrEP and other HIV prevention strategies for pregnant women and new mothers in high-prevalence settings.
Kristine Erlandson, M.D., an assistant professor of medicine with the University of Colorado, discusses significant issues related to caring for elderly HIV-positive patients.
Clinical trials have a long history of few, if any, women being recruited or enrolled. But an important U.S. study on HIV and heart disease is addressing the barriers that keep women out of research studies.
For HIV nurses, care often includes working with patients with mental illness and substance abuse issues.
Though deeply impacted by the virus, HIV may not be the first concern for transgender women.